Business · 1 sources covering this

Piramal Pharma cuts exposure to Chinese raw materials to reduce supply risk

Piramal is among global drugmakers increasingly seeking to reduce their reliance on China for pharmaceutical ingredients and manufacturing, amid rising geopolitical tensions

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
Piramal Pharma cuts exposure to Chinese raw materials to reduce supply risk
Piramal is among global drugmakers increasingly seeking to reduce their reliance on China for pharmaceutical ingredients and manufacturing, amid rising geopolitical tensions
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/0114e38677cfabfe68c1bd8c98904f08d4dad3b2"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Piramal Pharma cuts exposure to Chinese raw materials to reduce supply risk"></iframe>

Piramal Pharma cuts exposure to Chinese raw materials to reduce supply risk

How 1 sources are covering this

Piramal Pharma cuts exposure to Chinese raw materials to reduce supply risk

More from Business

Navy to commission indigenous warship Samarthak

Netflix inks deal for FIFA World Cup 2030

IPO allotment case: Woman wins compensation

Sebi extends relaxation to revise fresh issue size till March 2027

Reader

Trust & legal

Across the network